Join our mailing list
Get exclusive deals and learn about new products!
Reliable shipping
Flexible returns
In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most volumes published on cannabinoids so far concentrate on the biological activity, biochemistry and pharmacology, whereas this volume concentrates on the diseases, the physiological effects and therapeutic use of cannabinoids. The volume editor Prof. Mechoulam was the first who isolated the prime active constituent (THC, Tetrahydrocannabiol) of marijuana. He published extensively on the pharmacological activities of cannabinoids. The volume is of interest to researchers and clinicians from pharmacology, neuroscience, and medicinal research.
Published by: Birkhäuser
Publication Date: 2005-05-19
Format: Hardcover
ISBN-13: 9783764370558
DOI: 10.1007/3-7643-7358-X
Dimensions: 244cm x170cm
Pages: 268